Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.
Braun J, Zochling J, Baraliakos X, Alten R, Burmester G, Grasedyck K, Brandt J, Haibel H, Hammer M, Krause A, Mielke F, Tony HP, Ebner W, Gömör B, Hermann J, Zeidler H, Beck E, Baumgaertner M, Sieper J. Braun J, et al. Among authors: tony hp. Ann Rheum Dis. 2006 Sep;65(9):1147-53. doi: 10.1136/ard.2006.052878. Epub 2006 Apr 10. Ann Rheum Dis. 2006. PMID: 16606646 Free PMC article. Clinical Trial.
Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S, Tony HP, Krueger K, Detert J, Mielke F, Rockwitz K, Schwenke R, Burmester GR, Diel R, Feuchtenberger M, Kneitz C. Kleinert S, et al. Among authors: tony hp. Ann Rheum Dis. 2012 Nov;71(11):1791-5. doi: 10.1136/annrheumdis-2011-200941. Epub 2012 May 14. Ann Rheum Dis. 2012. PMID: 22586160 Clinical Trial.
[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs].
Fiehn C, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Krause A, Kuipers J, Lorenz HM, Müller-Ladner U, Nothacker M, Nüsslein H, Rubbert-Roth A, Schneider M, Schulze-Koops H, Seitz S, Sitter H, Specker C, Tony HP, Wassenberg S, Wollenhaupt J, Krüger K. Fiehn C, et al. Among authors: tony hp. Z Rheumatol. 2018 Aug;77(Suppl 2):35-53. doi: 10.1007/s00393-018-0481-y. Z Rheumatol. 2018. PMID: 29968101 Review. German.
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm].
Krüger K, Wollenhaupt J, Albrecht K, Alten R, Backhaus M, Baerwald C, Bolten W, Braun J, Burkhardt H, Burmester G, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Kuipers J, Krause A, Lorenz HM, Manger B, Nüßlein H, Pott HG, Rubbert-Roth A, Schneider M, Specker C, Schulze-Koops H, Tony HP, Wassenberg S, Müller-Ladner U; European League of Associations for Rheumatology (EULAR). Krüger K, et al. Among authors: tony hp. Z Rheumatol. 2012 Sep;71(7):592-603. doi: 10.1007/s00393-012-1038-0. Z Rheumatol. 2012. PMID: 22930110 German.
[Current therapeutic strategy for rheumatoid arthritis].
Wollenhaupt J, Alten R, Burkhardt H, Edelmann E, Gromnica-Ihle E, Krause A, Krüger K, Manger B, Lorenz H, Müller-Ladner U, Nüsslein H, Pott HG, Tony H, Schneider M. Wollenhaupt J, et al. MMW Fortschr Med. 2006 Oct 19;148(42):38-42; quiz 43. MMW Fortschr Med. 2006. PMID: 17621798 German.
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis].
Kalden JR, Burkhardt H, Buss B, Donhauser-Gruber U, Erstling U, Gromnica-Ihle E, Karberg K, Karger T, Kneitz CH, Krause A, Krüger K, Lorenz HM, Müller-Ladner U, Rubbert-Roth A, Steffens-Korbanka P, Tony HP, Wendler J, Wollenhaupt J, Burmester G. Kalden JR, et al. Among authors: tony hp. Z Rheumatol. 2011 Oct;70(8):641-50. doi: 10.1007/s00393-011-0763-0. Z Rheumatol. 2011. PMID: 21979315 Review. German.
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID).
Witt M, Grunke M, Proft F, Baeuerle M, Aringer M, Burmester G, Chehab G, Fiehn C, Fischer-Betz R, Fleck M, Freivogel K, Haubitz M, Kötter I, Lovric S, Metzler C, Rubberth-Roth A, Schwarting A, Specker C, Tony HP, Unger L, Wassenberg S, Dörner T, Schulze-Koops H; German Registry of Autoimmune Diseases (GRAID) Investigators. Witt M, et al. Among authors: tony hp. Lupus. 2013 Oct;22(11):1142-9. doi: 10.1177/0961203313503912. Lupus. 2013. PMID: 24057058
207 results